Latin America In Vitro Diagnostics (IVD) Market

Latin America In Vitro Diagnostics (IVD) Market Size, Share & Trends
Analysis Report and Segment Forecast, 2024 | Grand View Research, Inc
“The
growing population base, favorable government insurance policies, and
improved healthcare infrastructure are the high impact rendering growth
drivers of the Latin America IVD market.”
The Latin America IVD Market is expected to reach over USD 5.1 billion by 2024, according to a new report by
Grand View Research, Inc. The Latin America IVD market is expected to grow at a significant CAGR till 2024 owing
to the rising prevalence of target disorders, aging population, and the presence of favorable government initiatives
for early disease diagnosis. Other factors that are anticipated to boost the growth include the introduction of
technologically advanced instruments and the increasing R&D initiatives for the development of disease-specific
kits.
Regular testing for diabetes, cardiovascular, cancer, and sexually transmitted diseases are necessary for the timely
treatments, further avoiding the risk of fatal health complications. The availability of tests for home and near
patient testing is estimated to further enhance the usage rates of these devices. From November 2015, the Anvisa,
which is a regulatory body for medical devices in Brazil, has started allowing the registration for HIV self-testing
kits.
The increasing adoption point of care devices coupled with the increasing awareness among the healthcare
professionals regarding the early diagnosis of various diseases has provided a boost to the Latin IVD market. The
rising epidemic of communicable diseases in the southernpart of Latin America, the growing need for rapid and
accurate diagnostics, and the changing healthcare infrastructure scenario are some of the key drivers of the Latin
IVD market.
Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/latin-america-in-vitrodiagnostics-ivd-market
Follow Us:
Further key findings from the study suggest:

The instrument segment is one of the most important segments of in vitro diagnostics. The presence of
highly automated analyzers and the availability of over the counter products are some of the factors
responsible for its significant share.

The Molecular diagnostics segment is anticipated to be the fastest growing technology over the decade.
Molecular diagnostics is a transformative area of diagnostics. The continuous innovation in technology
helps the physicians for critical decision making

The infectious disease segment held the largest share in 2015 over 24% owing to the presence of favorable
government initiatives in association with the WHO to curb communicable diseases.

The home care segment is estimated to witness a significant growth over the forecast period. The high
number of R&D initiatives undertaken by key competitors for the development of portable IVD devices with
improved sensitivity and user-friendliness is a key factor attributing towards its growth.

In 2015, Brazil was the largest regional segment with a revenue generation of over USD 1.2 billion owing to
the established healthcare infrastructure, growing awareness for cancer screening, and the increasing
demand for genetic testing.

Peru is expected to be one of the fastest growing regions on account of the growing economic stability,
high unmet clinical needs, and the rising disposable incomes

Key players operating in the Latin America IVD market are Roche Diagnostics, Abbott Laboratories, Inc.,
Hologic (Gen-Probe), Becton Dickinson (BD) Company, Alere, Inc., Bio-Rad Laboratories, Qiagen N.V., Inc.,
bioMerieux, BioQuidel Corporation, and Siemens Healthcare.
Grand View Research has segmented the Latin America IVD market on the basis of product, technology,
application, end-use, and region:
Latin America IVD Market Product Outlook (Revenue, USD Million, 2013 - 2024)

IVD Instruments

IVD Reagents

Software
Latin America IVD Market Technology Outlook (Revenue, USD Million, 2013 - 2024)

Immunochemistry

Microbiology

Molecular Diagnostics
Follow Us:

Hematology

Clinical Chemistry

Coagulation

Other Clinical Instruments
Latin America IVD Market Application Outlook (Revenue, USD Million, 2013 - 2024)

Infectious Disease

Diabetes

Oncology/Cancer

Cardiology

Nephrology

Autoimmune Disease

Drug Testing

Others
Latin America IVD Market End-use Outlook (Revenue, USD Million, 2013 - 2024)

Hospitals

Laboratory

Home Care

Others
Latin America IVD Market Regional Outlook (Revenue, USD Million, 2013 - 2024)

Brazil

Mexico

Peru

Chile

Colombia

Argentina and Venezuela
Follow Us:
Table of Content of Latin America IVD Market
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Latin America IVD Market- Industry Snapshot and Key Buying Criteria, 2015
Chapter 3. Latin America IVD Industry Outlook
3.1. Latin America IVD Market Segmentation
3.2. Latin America IVD Market Size and Growth Outlook
3.3. Latin America IVD Market Dynamics
3.3.1. Market Drivers Estimates
3.3.1.1. Substantial Increase in Geriatric Population in Latin America
3.3.1.2. Considerable Prevalence of Chronic Disease
3.3.1.3. Growing Need for Point of Care Facilities.
3.3.2. Market Restraint Estimates
3.3.2.1. Lesser Rate of Reimbursement
3.3.2.2. Stringent Regulatory Background
3.4. Market Estimates - Porter’s
3.5. Latin America IVD Market PESTEL Estimates, 2015
Chapter 4. Latin America IVD Product Outlook
4.1. Latin America IVD Market Share by Product, 2015 & 2024
4.2. Instruments
4.2.1. Instruments Market Estimates and Forecasts, 2013 - 2024
4.3. Reagents
4.3.1. Reagents Market Estimates and Forecasts, 2013 - 2024
4.4. Software
4.4.1. Software Market Estimates and Forecasts, 2013 - 2024
Chapter 5. Latin America IVD Technology Outlook
5.1. Latin America IVD Market Share by technology, 2015 & 2024
5.2. Immunochemistry
Follow Us:
5.2.1. Immunochemistry Market Estimates and Forecasts, 2013 - 2024
5.3. Hematology
5.3.1. Hematology Market Estimates and Forecasts, 2013 - 2024
5.4. Clinical Chemistry
5.4.1. Clinical Chemistry Market Estimates and Forecasts, 2013 - 2024
5.5. Molecular Diagnostics
5.5.1. Molecular Diagnostics Market Estimates and Forecasts, 2013 - 2024
5.6. Coagulation
5.6.1. Coagulation Market Estimates and Forecasts, 2013 - 2024
5.7. Microbiology
5.7.1. Microbiology Market Estimates and Forecasts, 2013 - 2024
5.8. Other Clinical Technology
5.8.1. Other Clinical Technology Market Estimates and Forecasts, 2013 - 2024
Chapter 6. Latin America IVD Application Outlook
6.1. Latin America IVD Market Share by Application, 2015 & 2024
6.2. Infectious Disease
6.2.1. Infectious Disease Market Estimates and Forecasts, 2013 - 2024
6.3. Diabetes
6.3.1. Diabetes Market Estimates and Forecasts, 2013 - 2024
6.4. Oncology/Cancer
6.4.1. Oncology/Cancer Market Estimates and Forecasts, 2013 - 2024
6.5. Cardiology
6.5.1. Cardiology Market Estimates and Forecasts, 2013 - 2024
6.6. Nephrology
6.6.1. Nephrology Market Estimates and Forecasts, 2013 - 2024
6.7. Autoimmune Diseases
6.7.1. Autoimmune Diseases Market Estimates and Forecasts, 2013 - 2024
6.8. Drug Testing
6.8.1. Drug Testing Market Estimates and Forecasts, 2013 - 2024
6.9. Others
6.9.1. Others Market Estimates and Forecasts, 2013 - 2024
Follow Us:
Chapter 7. Latin America IVD End-use Outlook
7.1. Latin America IVD Market Share by End-use, 2015 & 2024
7.2. Hospitals
7.2.1. Hospitals Market Estimates and Forecasts, 2013 - 2024
7.3. Laboratory
7.3.1. Laboratory Market Estimates and Forecasts, 2013 - 2024
7.4. Home Care
7.4.1. Home Care Market Estimates and Forecasts, 2013 - 2024
7.5. Others
7.5.1. Others Market Estimates and Forecasts, 2013 - 2024
Chapter 8. Latin America IVD Regional Outlook
8.1. Latin America Market Share by Region, 2015 & 2024
8.2. Brazil
8.2.1. Brazil IVD Market, 2013 - 2024 (USD Million)
8.3. Mexico
8.3.1. Mexico IVD Market, 2013 - 2024 (USD Million)
8.4. Peru
8.4.1. Peru IVD Market, 2013 - 2024 (USD Million)
8.5. Chile
8.5.1. Chile IVD Market, 2013 - 2024 (USD Million)
8.6. Colombia
8.6.1. Colombia IVD Market, 2013 - 2024 (USD Million)
8.7. Argentina
8.7.1. Argentina IVD Market, 2013 - 2024 (USD Million)
8.8. Venezuela
8.8.1. Venezuela IVD Market, 2013 - 2024 (USD Million)
Chapter 9. Competitive Landscape
9.1. Becton Dickinson
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
Follow Us:
9.1.4. Strategic Initiatives
9.2. bioMerieux
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product Benchmarking
9.2.4. Strategic Initiatives
9.3. Abbott Laboratories
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product Benchmarking
9.3.4. Strategic Initiatives
9.4. Quidel Corporation
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product Benchmarking
9.4.4. Strategic Initiatives
9.5. Alere, Inc.
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Strategic Initiatives
9.6. OraSure Technologies
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product Benchmarking
9.6.4. Strategic Initiatives
9.7. Hologic (Gen Probe)
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product Benchmarking
9.7.4. Strategic Initiatives
Follow Us:
9.8. Cepheid Inc.
9.8.1. Company Overview
9.8.2. Financial Performance
9.8.3. Product Benchmarking
9.8.4. Strategic Initiatives
9.9. Qiagen N.V.
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. Product Benchmarking
9.9.4. Strategic Initiatives
9.10. Roche Diagnostics
9.10.1. Company Overview
9.10.2. Financial Performance
9.10.3. Product Benchmarking
9.10.4. Strategic Initiatives
9.11. Siemens Healthcare
9.11.1. Company Overview
9.11.2. Financial Performance
9.11.3. Product Benchmarking
9.11.4. Strategic Initiatives
9.12. Bio-Rad Laboratories
9.12.1. Company Overview
9.12.2. Financial Performance
9.12.3. Product Benchmarking
9.12.4. Strategic Initiatives
Follow Us:
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed business decisions, the company offers
market intelligence studies ensuring relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
Follow Us:

The latin america IVD market is expected to reach over USD 5.1 billion by 2024, according to a new report by Grand View Research, Inc.

Download Report